Skip to content

Amputee Gait Training Using Virtual Reality and Real-Time Feedback

Amputee Gait Training Using Virtual Reality and Real-Time Feedback

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01225120
Acronym
VRGAIT
Enrollment
66
Registered
2010-10-20
Start date
2007-08-31
Completion date
Unknown
Last updated
2010-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Gait Kinematics

Brief summary

The purpose of this repeated measures design gait training study is to develop and quantitatively assess the effectiveness of a virtual reality training environment using real-time feedback for modification of pelvic motion during gait.

Interventions

OTHERGait Training

12 sessions, 30 minutes of walking on treadmill with real time therapist directed feedback on gait kinematics.

Sponsors

Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Unilateral traumatic trans-tibial or transfemoral amputation * Independent ambulation without an assistive device for a minimum of three months * Ability to ambulate continuously for a minimum of 15 minutes * Trans-femoral participants must use an ischial containment socket * VAS Pain scores on the involved side of less than 4/10 * Sagittal plane ankle, knee and hip strength of 4 or greater on the uninvolved side as determined by manual muscle test.

Exclusion criteria

* Blindness * TBI-Glascow Coma Scale score of 12 or lower at the time of injury * Cardiac or pulmonary problems limiting physical activity * PTSD or other psychological condition with symptoms that would be exacerbated by participation in the study.

Design outcomes

Primary

MeasureTime frame
Gait Biomechanics3 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026